drugset / Trial / NCT01897519
A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-05
- Completion
- 2014-05
Outcome
Outcome not reported
Stopped: “Topline results from study M13-796 showed an overall lack of efficacy. There were no safety concerns.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MODIMELANOTIDE | Protein / enzyme biologic | — | — |
Indications
No indication recorded.